Received Jul 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y015599 | IM / LL |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | y015599 | — |
No additional AEs were reported; 2 month old patient received a dose of GARDASIL 9; This spontaneous report was received from healthcare worker and refers to a 2-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 03-Jul-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #y015599, expiration date: 10-Feb-2027) (strength, dose, frequency, and anatomical location were not reported), 1 dose, for prophylaxis (Product administered to patient of inappropriate age). No adverse event reported. Lot # is being requested and will be submitted if received.